4.7 Article

Artesunate and dihydroartemisinin-piperaquine treatment failure in a severe Plasmodium falciparum malaria case imported from Republic of C?te d?Ivoire

Related references

Note: Only part of the references are listed.
Article Infectious Diseases

Recrudescence of a high parasitaemia, severe Plasmodium falciparum malaria episode, treated by artesunate monotherapy

Sophie Landre et al.

Summary: A patient with severe malaria and hyperparasitaemia was initially treated with 7-day artesunate monotherapy, which led to a severe recrudescence due to hyperparasitaemia, monotherapy, and a polyclonal infection without Kelch 13 gene mutation. Subsequent treatments with artesunate, quinine, and artemether-lumefantrine were successful in curing the patient.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Review Infectious Diseases

Artemisinin and multidrug-resistant Plasmodium falciparum - a threat for malaria control and elimination

Mehul Dhorda et al.

Summary: Artemisinin-resistant Plasmodium falciparum has emerged in various regions, leading to significant ACT treatment failures. Aggressive malaria elimination programs in the Greater Mekong Subregion have been successful in preventing the spread of resistance, but mutations in the pfk13 gene have appeared in other parts of Asia, Africa, and South America. Enhanced surveillance and treatment strategies are necessary to address emerging resistance and prevent multidrug resistance.

CURRENT OPINION IN INFECTIOUS DISEASES (2021)

Article Public, Environmental & Occupational Health

Monitoring for multidrug-resistant Plasmodium falciparum isolates and analysis of pyrimethamine resistance evolution in Uige province, Angola

Michela Menegon et al.

TROPICAL MEDICINE & INTERNATIONAL HEALTH (2009)

Article Parasitology

Contribution of the pfmdr1 gene to antimalarial drug-resistance

MT Duraisingh et al.

ACTA TROPICA (2005)